Samsung joins other developers by introducing an ECG-enabled smartwatch, but single-lead ECG prediction of atrial fibrillation (AFib) events is still an industrywide challenge

August 07, 2019 | Case Study

A report from Wareable claims that Samsung will feature ECG-sensing capability in its upcoming smartwatch, the Galaxy Watch Active 2, in the first half of 2020. If this claim is accurate, Samsung now joins Apple, Withings, and Verily as the next tech developer that plans to enter the cardiac care space using smartwatches in predicting atrial fibrillation (AFib).

Related companies	Samsung, Apple, Withings, Verily

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978